Among therapeutic mAbs, the most effective drugs include adalimumab (Humira), an mAb used to treat rheumatoid arthritis, and bevacizumab (Avastin) which targets vascular endothelial growth factor (VEGF) and inhibits the growth of blood vessels (19). The gene discussed is VEGFA; the disease is rheumatoid arthritis.